• No results found

The role of ApoCI, LPL and CETP in plasma lipoprotein metabolism - studies in mice Hoogt, C.C. van der

N/A
N/A
Protected

Academic year: 2021

Share "The role of ApoCI, LPL and CETP in plasma lipoprotein metabolism - studies in mice Hoogt, C.C. van der"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

The role of ApoCI, LPL and CETP in plasma lipoprotein

metabolism - studies in mice

Hoogt, C.C. van der

Citation

Hoogt, C. C. van der. (2006, November 28). The role of ApoCI, LPL and CETP

in plasma lipoprotein metabolism - studies in mice. Retrieved from

https://hdl.handle.net/1887/5414

Version:

Corrected Publisher’s Version

License:

Licence agreement concerning inclusion of doctoral

thesis in the Institutional Repository of the University

of Leiden

Downloaded from:

https://hdl.handle.net/1887/5414

(2)

The Role of ApoCI, LPL and CETP in

Plasma Lipoprotein Metabolism

(3)
(4)

The Role of ApoCI, LPL and CETP in

Plasma Lipoprotein Metabolism

Studies in Mice

PROEFSCHRIFT ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van de Rector Magnifi cus Dr. D.D. Breimer,

hoogleraar in de faculteit der Wiskunde en Natuurwetenschappen en die der Geneeskunde,

volgens besluit van het College voor Promoties te verdedigen op dinsdag 28 november 2006

klokke 15.00 uur

door

Cornelia Catharina van der Hoogt geboren te Apeldoorn

(5)

Promotiecommissie

Promotor: Prof. Dr. L.M. Havekes Co-promotor: Dr. P.C.N. Rensen

Referent: Dr. J.A. Kuivenhoven (AMC, Amsterdam) Overige leden: Prof. Dr. B. Staels (Inserm, Lille, Frankrijk) Prof. Dr. J.W. Jukema

Prof. Dr. R.R. Frants

The studies described in this thesis were supported by a grant from the Netherlands Or-ganization of Scientifi c Research (NWO/ZonMW 908-02-097). The studies were per-formed at the Gaubius Laboratories of TNO-Quality of Life and the Leiden University Medical Center, Leiden, The Netherlands.

The printing of this thesis was fi nincially supported by: The Dutch Atherosclerosis Society (DAS)

(6)

Gij kent mijn zitten en mijn opstaan, Gij verstaat van verre mijn gedachten; Gij onderzoekt mijn gaan en mijn liggen, met al mijn wegen zijt Gij vertrouwd. Want er is geen woord op mijn tong, of, zie, HERE, Gij kent het volkomen;

Gij omgeeft mij van achteren en van voren en Gij legt uw hand op mij. Het begrijpen is mij te wonderbaar, te verheven, ik kan er niet bij. Psalm 139: 2-6

(7)

Printing: PrintPartners Ipskamp B.V., Enschede, The Netherlands Cover: C.C. van der Hoogt/Foto Korenhof

ISBN-10: 90-9020858-5 ISBN-13: 978-90-9020858-9

Van der Hoogt, Cornelia Catharina

The role of apoCI, LPL and CETP in plasma lipoprotein metabolism. Studies in mice. Proefschrift Leiden.

Met literatuuropgave - Met samenvatting in het Nederlands

© 2006 Cornelia Catharina van der Hoogt.

(8)

Table of Contents

Chapter 1 General Introduction

Chapter 2 Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by ApoCI-induced inhibition of LPL Chapter 3 Apolipoprotein CI causes hypertriglyceridemia

independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice

Chapter 4 The hepatic clearance of VLDL in the absence of the three major apoE-recognizing receptors is dependent on LPL

Chapter 5 ApoE*2-associated hyperlipidemia is ameliorated by increased levels of apoAV, but unaffected by defi ciency

Chapter 6 Cholesteryl ester transfer protein decreases HDL and severely aggravates atherosclerosis in APOE*3-Leiden mice

Chapter 7 Fenofi brate increases HDL cholesterol by reducing the expression of cholesteryl ester transfer protein

Chapter 8 Atorvastatin increases HDL cholesterol by reducing cholesteryl ester transfer protein

(9)

Referenties

GERELATEERDE DOCUMENTEN

However, atorvastatin did not increase hepatic Apoa1 expression or plasma apoAI levels either in E3L mice nor in CETP.E3L mice... poor apoAI is subsequently lipidated

Treatment of CETP.E3L mice with fenofi brate resulted in an increased HDL-cholesterol level, strongly decreased hepatic CETP expression levels, and reduced plasma CETP mass

to cholesterol effl ux, plasma from CETP.E3L mice showed a decreased SR-BI mediated cholesterol effl ux despite higher VLDL levels.. It remains to be elucidated whether

The absence of a hypolipidemic effect of Apoc3-defi ciency in APOE*2 mice indicates that the defect in APOE*2-associated hyperlipidemia is upstream from the positive effect

However, mice that were treated with AdAPOC1 had similar post-heparin LPL plas- ma levels (Table 1), in addition to similar levels of LPL protein (295±40 vs. This is in agreement

Upon administration of AdAPOC1 to wild-type mice, apoCI dose-dependently increased plasma lipid levels, with a p referential increase of TG as compared to TC, which is specifi c

human apoCI is highly expressed in the liver, we did not detect any effect of human apoCI expression on hepatic VLDL-TG production rate on both a wild-type and apoE- defi

Apoa5 defi cient mice displayed 4-fold increased plasma TG levels, whereas over- expression of human APOA5 in mice reduced TG by 65%. 132 In addition, adenoviral expression of